The impact of priming on memory of clinical HIV-1 clade CNYVAC based vaccine candidates in rhesus macaques

被引:0
|
作者
Mooij, P.
Balla-Jaghjoorsingh, S.
Beenhakker, N.
van Haaften, P.
Baak, I.
Nieuwenhuis, I.
Harari, A.
Pantaleo, G.
Frachette, Marie-Joelle
Heidari, S.
Wolf, H.
Wagner, R.
Lijestrom, P.
Heeney, J. L.
机构
[1] Biomed Primate Res Ctr, Rijswijk, Netherlands
[2] Univ Vaudois, Ctr Hosp, Lausanne, Switzerland
[3] Sanofi Pasteur, Marcy Letoile, France
[4] Karolinska Inst, S-10401 Stockholm, Sweden
[5] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-8400 Regensburg, Germany
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
48
引用
收藏
页码:305 / 305
页数:1
相关论文
共 50 条
  • [21] Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
    Marie-Noëlle Takahashi
    Judith A Rolling
    Katherine E Owen
    Virology Journal, 7
  • [22] Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
    Giel-Moloney, M.
    Esteban, M.
    Oakes, B. H.
    Vaine, M.
    Asbach, B.
    Wagner, R.
    Mize, G. J.
    Spies, A. G.
    McElrath, J.
    Perreau, M.
    Roger, T.
    Ives, A.
    Calandra, T.
    Weiss, D.
    Perdiguero, B.
    Kibler, K. V.
    Jacobs, B.
    Ding, S.
    Tomaras, G. D.
    Montefiori, D. C.
    Ferrari, G.
    Yates, N. L.
    Roederer, M.
    Kao, S. F.
    Foulds, K. E.
    Mayer, B. T.
    Bennett, C.
    Gottardo, R.
    Parrington, M.
    Tartaglia, J.
    Phogat, S.
    Pantaleo, G.
    Kleanthous, H.
    Pugachev, K. V.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
    Berger, Alice
    Pedersen, Jannie
    Kowatsch, Monika M.
    Scholte, Florine
    Lafrance, Marc-Alexandre
    Azizi, Hiva
    Li, Yue
    Gomez, Alejandro
    Wade, Matthew
    Fausther-Bovendo, Hugues
    de la Vega, Marc-Antoine
    Jelinski, Joseph
    Babuadze, George
    Nepveu-Traversy, Marie-Edith
    Lamarre, Claude
    Racine, Trina
    Kang, Chil-Yong
    Gaillet, Bruno
    Garnier, Alain
    Gilbert, Renald
    Kamen, Amine
    Yao, Xiao-Jian
    Fowke, Keith R.
    Arts, Eric
    Kobinger, Gary
    VACCINES, 2024, 12 (04)
  • [24] Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
    M. Giel-Moloney
    M. Esteban
    B. H. Oakes
    M. Vaine
    B. Asbach
    R. Wagner
    G. J. Mize
    A. G. Spies
    J. McElrath
    M. Perreau
    T. Roger
    A. Ives
    T. Calandra
    D. Weiss
    B. Perdiguero
    K. V. Kibler
    B. Jacobs
    S. Ding
    G. D. Tomaras
    D. C. Montefiori
    G. Ferrari
    N. L. Yates
    M. Roederer
    S. F. Kao
    K. E. Foulds
    B. T. Mayer
    C. Bennett
    R. Gottardo
    M. Parrington
    J. Tartaglia
    S. Phogat
    G. Pantaleo
    H. Kleanthous
    K. V. Pugachev
    Scientific Reports, 9
  • [25] Impact of in vivo CD4 binding during HIV-1 Env trimer immunizations of rhesus macaques
    Douagi, I.
    Forsell, M. M.
    Sundling, C.
    O'dell, S.
    Seder, R.
    Mascola, J. R.
    Lore, K.
    Wyatt, R. T.
    RETROVIROLOGY, 2009, 6
  • [26] Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
    Takahashi, Marie-Noelle
    Rolling, Judith A.
    Owen, Katherine E.
    VIROLOGY JOURNAL, 2010, 7
  • [27] A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
    Sahoo, Anusmita
    Jones, Andrew T.
    Cheedarla, Narayanaiah
    Gangadhara, Sailaja
    Roy, Vicky
    Styles, Tiffany M.
    Shiferaw, Ayalnesh
    Walter, Korey L.
    Williams, LaTonya D.
    Shen, Xiaoying
    Ozorowski, Gabriel
    Lee, Wen-Hsin
    Burton, Samantha
    Yi, Lasanajak
    Song, Xuezheng
    Qin, Zhaohui S.
    Derdeyn, Cynthia A.
    Ward, Andrew B.
    Clements, John D.
    Varadarajan, Raghavan
    Tomaras, Georgia D.
    Kozlowski, Pamela A.
    Alter, Galit
    Amara, Rama Rao
    SCIENCE IMMUNOLOGY, 2022, 7 (73)
  • [28] Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
    P Munseri
    A Kroidl
    C Nilsson
    C Moshiro
    S Aboud
    A Joachim
    C Geldmacher
    E Aris
    D Buma
    E Lyamuya
    F Gotch
    K Godoy-Ramirez
    K Pallangyo
    L Maboko
    M Marovich
    M Robb
    M Hoelscher
    M Janabi
    P Mann
    S Joseph
    S Mfinanga
    W Stoehr
    F Mhalu
    B Wahren
    G Biberfeld
    S McCormack
    E Sandstrom
    M Bakari
    Retrovirology, 9
  • [29] Priming with a "simplified regimen" of HIV-1 DNA vaccine is as good as a "standard regimen" when boosted with heterologous HIV-1 MVA vaccine
    Munseri, P.
    Kroidl, A.
    Nilsson, C.
    Moshiro, C.
    Aboud, S.
    Joachim, A.
    Geldmacher, C.
    Aris, E.
    Buma, D.
    Lyamuya, E.
    Gotch, F.
    Godoy-Ramirez, K.
    Pallangyo, K.
    Maboko, L.
    Marovich, M.
    Robb, M.
    Hoelscher, M.
    Janabi, M.
    Mann, P.
    Joseph, S.
    Mfinanga, S.
    Stoehr, W.
    Mhalu, F.
    Wahren, B.
    Biberfeld, G.
    McCormack, S.
    Sandstrom, E.
    Bakari, M.
    RETROVIROLOGY, 2012, 9
  • [30] Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
    Munseri, Patricia. J.
    Kroidl, Arne
    Nilsson, Charlotta
    Joachim, Agricola
    Geldmacher, Christof
    Mann, Philipp
    Moshiro, Candida
    Aboud, Said
    Lyamuya, Eligius
    Maboko, Leonard
    Missanga, Marco
    Kaluwa, Bahati
    Mfinanga, Sayoki
    Podola, Lilly
    Bauer, Asli
    Godoy-Ramirez, Karina
    Marovich, Mary
    Moss, Bernard
    Hoelscher, Michael
    Gotch, Frances
    Stoehr, Wolfgang
    Stout, Richard
    McCormack, Sheena
    Wahren, Britta
    Mhalu, Fred
    Robb, Merlin L.
    Biberfeld, Gunnel
    Sandstrom, Eric
    Bakari, Muhammad
    PLOS ONE, 2015, 10 (04):